Cancer Family
Vascular Neoplasm
CI-CAN-00000385Explore in graph →
Loading cancer entity…
Cancer Family
CI-CAN-00000385Explore in graph →
Variants & evidence
13 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| FOSB Fusion1 | ||||||||
| (diagnostic) | Pseudomyogenic Hemangioendothelioma | Diagnostic | B | Supports Positive | 4 | accepted | EID12779In this 2019 study, targeted RNA sequencing using the Archer FusionPlex technology was validated and implemented to detect oncogenic fusion transcripts in 62 genes recurrently rearranged in solid tumo… (full text at CIViC) PMID 30459475 · Zhu et al., 2019 · Open in CIViC | civic |
| FLT4 Amplification1 | ||||||||
| Pazopanib | Angiosarcoma | Predictive | C | Supports Sensitivity Response | 3 | submitted | EID5911One patient with angiosarcoma was initially treated with sorafenib, an inhibitor of VEGFR2, and developed progressive disease. The patient then received pazopanib, an inhibitor of VEGFR2 and VEGFR3 an… (full text at CIViC) PMID 27160228 · Ravi et al., 2016 · Open in CIViC | civic |
| WWTR1 Fusion1 | ||||||||
| (diagnostic) | Pseudomyogenic Hemangioendothelioma | Diagnostic | C | Supports Positive | 4 | accepted | EID12752In this study, the authors investigated a case of pseudomyogenic hemangioendothelioma in a 33-year-old woman presenting with multifocal lytic bone lesions. Previous studies had demonstrated recurrent … (full text at CIViC) PMID 31243110 · Panagopoulos et al., 2019 · Open in CIViC | civic |
| FOS Fusion1 | ||||||||
| (diagnostic) | Bone Epithelioid Hemangioma | Diagnostic | C | Supports Positive | 3 | accepted | EID1802FOS was found fused with 3 different genes in 3 cases of bone epithelioid hemangioma. The fusion partners were not recurrent, respectively MBNL1, VIM and a lincRNA. The truncation of the FOS gene wou… (full text at CIViC) PMID 26173738 · van IJzendoorn et al., 2015 · Open in CIViC | civic |
| GNA11 G209P1 | ||||||||
| (prognostic) | Congenital Hemangioma | Prognostic | C | Supports Poor Outcome | 3 | submitted | EID8640An infant was diagnosed prenatally at 20 weeks gestation with segmented vascular tumors involving her liver, umbilicus, and skin of the upper back and torso. She developed congestive heart failure imm… (full text at CIViC) PMID 32255239 · Smith et al., 2020 · Open in CIViC | civic |
| GNAQ G209P1 | ||||||||
| (prognostic) | Congenital Hemangioma | Prognostic | C | Supports Poor Outcome | 3 | submitted | EID8641A 33-week gestational age male infant was prematurely delivered due to ultrasound findings of a large mass on his upper trunk. Segmentally distributed purple plaques were revealed on his right chest a… (full text at CIViC) PMID 32255239 · Smith et al., 2020 · Open in CIViC | civic |
| KDR A1065T1 | ||||||||
| Sorafenib + SunitinibSubstitutes | Angiosarcoma | Predictive | D | Supports Sensitivity Response | 3 | accepted | EID1106COS-7 cells were transiently transfected with expression constructs encoding cDNAs for wild-type or A1065T-mutant KDR. Autophosphorylation was observed on tyrosine of mutant cells, but not wild-type c… (full text at CIViC) PMID 19723655 · Antonescu et al., 2009 · Open in CIViC | civic |
| KDR Amplification1 | ||||||||
| Pazopanib | Angiosarcoma | Predictive | C | Supports Sensitivity Response | 3 | submitted | EID7139The angiosarcoma harbored amplifications of VEGFR2 (KDR) of 8 copies and VEGFR3 (FLT4) of 16 copies. The patient was initially treated with sorafenib, an inhibitor of VEGFR2, and developed progressive… (full text at CIViC) PMID 27160228 · Ravi et al., 2016 · Open in CIViC | civic |
| KDR D717V1 | ||||||||
| Sorafenib + SunitinibSubstitutes | Angiosarcoma | Predictive | D | Supports Sensitivity Response | 3 | accepted | EID1107COS-7 cells were transiently transfected with expression constructs encoding cDNAs for wild-type or D717V-mutant KDR. Autophosphorylation was observed on tyrosine of mutant cells, but not wild-type ce… (full text at CIViC) PMID 19723655 · Antonescu et al., 2009 · Open in CIViC | civic |
| KDR Overexpression1 | ||||||||
| Sunitinib | Breast Angiosarcoma | Predictive | C | Supports Sensitivity Response | 3 | submitted | EID5910gene expression assay performed earlier demonstrated a This case report of a patient with refractory breast angiosarcoma shows a potential therapeutic benefit of sunitinib due to the upregulation of V… (full text at CIViC) PMID 25639617 · Silva et al., 2015 · Open in CIViC | civic |
| PTPRB Loss-of-function2 | ||||||||
| (diagnostic) | Angiosarcoma | Diagnostic | B | Supports Positive | 3 | accepted | EID10079A cohort of angiosarcomas (n=36) was sequenced and revealed to contain recurrent mutations in PTPRB (10/36) which were predominantly truncating or splice variants which impact the tyrosine phosphotase… (full text at CIViC) PMID 24633157 · Behjati et al., 2014 · Open in CIViC | civic |
| Sunitinib + VatalanibSubstitutes | Angiosarcoma | Predictive | D | Supports Sensitivity Response | 3 | accepted | EID1895The endothelial phosphatase PTPRB, a negative regulator of vascular growth factor tyrosine kinases, harbored truncating mutations in 10 of 39 angiosarcomas (26%) which correlated with MYC amplificatio… (full text at CIViC) PMID 24633157 · Behjati et al., 2014 · Open in CIViC | civic |
| FOSB Fusion1 | ||||||||
| (diagnostic) | Pseudomyogenic Hemangioendothelioma | Diagnostic | B | Supports Positive | 3 | accepted | EID11785In this study, the authors analyzed two index cases of pseudomyogenic haemangioendothelioma and 10 additional cases by interphase FISH. Both index cases showed a balanced t(7;19)(q22;q13) translocatio… (full text at CIViC) PMID 24374978 · Walther et al., 2014 · Open in CIViC | civic |
Data updated 15 hours agoSource updated unknownsource: civic (CC0)
Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.